Vanda climbs on faster review for sleep drug Shares of Vanda...

Pharmaceuticals Inc. climbed Tuesday after the company said the Food and Drug Administration is planning a faster review of its sleep disorder drug said the FDA plans to complete its review by Jan. 31, taking less than the usual 10 months.

http://www.news.net/article/400870/Health/